about
Uric acid lowering therapies for preventing or delaying the progression of chronic kidney diseaseUremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemiaP wave dispersion and maximum P wave duration are independently associated with rapid renal function declineUric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review.New and improved strategies for the treatment of goutPrevalence and risk factors of hyperuricemia among kidney transplant recipients.Elevated uric acid increases the risk for kidney disease.Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?Genome-wide linkage analysis for uric acid in families enriched for hypertension.New insights into uric acid effects on the progression and prognosis of chronic kidney disease.Febuxostat and Increased Dialysis as a Treatment for Severe Tophaceous Gout in a Hemodialysis PatientRenoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis ratsPrevention of renal damage by treating hyperuricemia.Exercise-induced changes in renal URAT1 activity and expression in rats.Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease.Optical method for cardiovascular risk marker uric acid removal assessment during dialysis.
P2860
Q24235651-6082EB18-B77A-410A-B803-E0150DB00894Q33869303-B734A18F-15D7-4D87-B471-C9309635FF66Q33989505-9327D2F2-D474-4937-A335-99999A4A4433Q34404840-517B7C15-7033-4441-B9C2-C88DBDFE8A7CQ34682703-F1127972-F80E-497E-A676-F4CB0C76D295Q35026692-CB72F878-8181-4E00-8D4F-41F76590041BQ36954128-D76A10FC-E0E2-42D7-8F13-04101E6F9C38Q36985796-20D78305-7CAD-4110-AED0-B6DDC82F5B97Q37078795-060A2653-ED93-4FDA-8FC3-D11FB70DD979Q37324422-F73F596A-6AE7-4FFE-922E-EE93052692D1Q37977142-2A26112E-105D-4DA1-93E0-1F9521EE134FQ41008315-4539F6A1-6CA2-4662-B036-15D7810148A0Q41385892-6E3D6442-17C7-42AB-A019-D3206DCA9FCAQ41855458-C618A71A-0A02-4699-B64B-CE8836E1A68FQ42956404-72D9A026-6720-440D-8B15-7D52475FE65FQ47216784-33BABE1D-DBBD-4AA2-B7A0-BF88F21A2FFDQ47690427-CC03FE47-279E-47C4-B420-1A758FD96B26Q51354581-2B0FEF0D-C99C-475B-86C9-902E189FD632
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Uric acid--a uremic toxin?
@ast
Uric acid--a uremic toxin?
@en
type
label
Uric acid--a uremic toxin?
@ast
Uric acid--a uremic toxin?
@en
prefLabel
Uric acid--a uremic toxin?
@ast
Uric acid--a uremic toxin?
@en
P2093
P2860
P356
P1433
P1476
Uric acid--a uremic toxin?
@en
P2093
Duk-Hee Kang
Jaime Herrera-Acosta
L Gabriela Sánchez-Lozada
Marilda Mazzali
Richard J Johnson
Takahiko Nakagawa
P2860
P356
10.1159/000089440
P577
2006-01-01T00:00:00Z